State of the art of diagnosis of rickettsial diseases: the use of blood specimens for diagnosis of scrub typhus, spotted fever group rickettsiosis, and murine typhus

With improved malaria control, acute undifferentiated febrile illness studies in tropical regions reveal a startling proportion of rickettsial illnesses, especially scrub typhus, murine typhus, and spotted fever group rickettsioses. Laboratory diagnosis of these infections evolved little over the pa...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Paris, D, Dumler, J
Materiálatiipa: Journal article
Giella:English
Almmustuhtton: Lippincott, Williams & Wilkins 2016
_version_ 1826291565176291328
author Paris, D
Dumler, J
author_facet Paris, D
Dumler, J
author_sort Paris, D
collection OXFORD
description With improved malaria control, acute undifferentiated febrile illness studies in tropical regions reveal a startling proportion of rickettsial illnesses, especially scrub typhus, murine typhus, and spotted fever group rickettsioses. Laboratory diagnosis of these infections evolved little over the past 40 years, but combinations of technologies like PCR and loop-mediated isothermal amplification, with refined rapid diagnostic tests and/or ELISA, are promising for guidance for early antirickettsial treatment.The long-term reliance on serological tests - useful only late in rickettsial infections - has led to underdiagnosis, inappropriate therapies, and undocumented morbidity and mortality. Recent approaches integrate nucleic acid amplification and recombinant protein-based serological tests for diagnosing scrub typhus. Optimized using Bayesian latent class analyses, this strategy increases diagnostic confidence and enables early accurate diagnosis and treatment - a model to follow for lagging progress in murine typhus and spotted fever.A laboratory diagnostic paradigm shift in rickettsial infections is evolving, with replacement of indirect immunofluorescence assay by the more objective ELISA coupled with nucleic acid amplification assays to expand the diagnostic window toward early infection intervals. This approach supports targeted antirickettsial therapy, reduces morbidity and mortality, and provides a robust evidence base for further development of diagnostics and vaccines.
first_indexed 2024-03-07T03:01:18Z
format Journal article
id oxford-uuid:b10d06ab-554d-492a-81c7-a69fa015cb6d
institution University of Oxford
language English
last_indexed 2024-03-07T03:01:18Z
publishDate 2016
publisher Lippincott, Williams & Wilkins
record_format dspace
spelling oxford-uuid:b10d06ab-554d-492a-81c7-a69fa015cb6d2022-03-27T04:01:03ZState of the art of diagnosis of rickettsial diseases: the use of blood specimens for diagnosis of scrub typhus, spotted fever group rickettsiosis, and murine typhusJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b10d06ab-554d-492a-81c7-a69fa015cb6dEnglishSymplectic Elements at OxfordLippincott, Williams & Wilkins2016Paris, DDumler, JWith improved malaria control, acute undifferentiated febrile illness studies in tropical regions reveal a startling proportion of rickettsial illnesses, especially scrub typhus, murine typhus, and spotted fever group rickettsioses. Laboratory diagnosis of these infections evolved little over the past 40 years, but combinations of technologies like PCR and loop-mediated isothermal amplification, with refined rapid diagnostic tests and/or ELISA, are promising for guidance for early antirickettsial treatment.The long-term reliance on serological tests - useful only late in rickettsial infections - has led to underdiagnosis, inappropriate therapies, and undocumented morbidity and mortality. Recent approaches integrate nucleic acid amplification and recombinant protein-based serological tests for diagnosing scrub typhus. Optimized using Bayesian latent class analyses, this strategy increases diagnostic confidence and enables early accurate diagnosis and treatment - a model to follow for lagging progress in murine typhus and spotted fever.A laboratory diagnostic paradigm shift in rickettsial infections is evolving, with replacement of indirect immunofluorescence assay by the more objective ELISA coupled with nucleic acid amplification assays to expand the diagnostic window toward early infection intervals. This approach supports targeted antirickettsial therapy, reduces morbidity and mortality, and provides a robust evidence base for further development of diagnostics and vaccines.
spellingShingle Paris, D
Dumler, J
State of the art of diagnosis of rickettsial diseases: the use of blood specimens for diagnosis of scrub typhus, spotted fever group rickettsiosis, and murine typhus
title State of the art of diagnosis of rickettsial diseases: the use of blood specimens for diagnosis of scrub typhus, spotted fever group rickettsiosis, and murine typhus
title_full State of the art of diagnosis of rickettsial diseases: the use of blood specimens for diagnosis of scrub typhus, spotted fever group rickettsiosis, and murine typhus
title_fullStr State of the art of diagnosis of rickettsial diseases: the use of blood specimens for diagnosis of scrub typhus, spotted fever group rickettsiosis, and murine typhus
title_full_unstemmed State of the art of diagnosis of rickettsial diseases: the use of blood specimens for diagnosis of scrub typhus, spotted fever group rickettsiosis, and murine typhus
title_short State of the art of diagnosis of rickettsial diseases: the use of blood specimens for diagnosis of scrub typhus, spotted fever group rickettsiosis, and murine typhus
title_sort state of the art of diagnosis of rickettsial diseases the use of blood specimens for diagnosis of scrub typhus spotted fever group rickettsiosis and murine typhus
work_keys_str_mv AT parisd stateoftheartofdiagnosisofrickettsialdiseasestheuseofbloodspecimensfordiagnosisofscrubtyphusspottedfevergrouprickettsiosisandmurinetyphus
AT dumlerj stateoftheartofdiagnosisofrickettsialdiseasestheuseofbloodspecimensfordiagnosisofscrubtyphusspottedfevergrouprickettsiosisandmurinetyphus